The genetic and functional basis of the replicationdefective nature of human immunodeficiency virus type 1 (HIV-1) in monkey cells was studied. By the generation and characterization of chimeras between HIV-1 and simian immunodeficiency virus, the sequence encompassing the 3' half of the long terminal repeat, gag and pol genes of HIV-1 was found to be responsible for the growth restriction. Early and late phases of HIV-1 replication in monkey cells were analysed in detail using several assay systems: transfection/coculture, transcomplementation between various proviral clones carrying the CAT gene and effector clones and evaluation of transcription and reverse transcription. All the data were consistent with the notion that replication is blocked at a very early stage(s) such as uncoating and/or reverse transcription in monkey cells.
Introduction
The host range of retroviruses is determined by both cellular and viral factors which regulate viral replication. A number of mechanisms for host-range restriction have been proposed in retroviral systems. In many instances, cellular tropisms are determined by the interaction between the envelope glycoprotein and a specific cell surface receptor (for a review see Varmus & Swanstrom, 1984) . In that event, viral infection of resistant cells is blocked at the stage of viral entry (Varmus & Swanstrom, 1984) . However, there are several examples of intracellular restriction of retrovirus replication. In the Fv-1 restriction of murine leukaemia viruses (MuLVs), viral replication in resistant cells is blocked at the postpenetration level, but before proviral integration (Varmus & Swanstrom, 1984) . The viral determinant for the restriction maps to the Gag capsid protein, which may interact with cellular factor(s) encoded within the Fv-1 locus in the mouse genome (Varmus & Swanstrom, 1984) . Replication of an avian retrovirus, spleen necrosis virus (SNV), in primate cells is blocked at a posttranscriptional stage(s) such as protein processing or virion assembly (Koo et al., 1991) , because a gene * Author for correspondence. Fax +81 75 751 3995. e-mail aadati@virusl .virus.kyoto-u.ac.jp t Present address: LaboratoryofMolecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.
transduced by the SNV-based retrovector is stably expressed in the cells (Koo et al., 1991) .
Human and simian immunodeficiency viruses (HIV and SIV) are lentiviruses which replicate in T cells and monocytes/macrophages displaying a surface CD4 antigen, which is the receptor for HIV/SIV infection (Hoxie et at., 1988; Klatzmann et al., 1984) . The species tropism of HIV-1 is narrower than that of viruses of the HIV-2 subgroup (HIV-2, SIV~A c and SIVMN E of the macaque monkey and SIVsM of the sooty mangabey, Cercocebus atys). Only higher primates [humans, chimpanzees (Pan troglodytes), gibbons (Hylobates lar)] and pig-tailed macaques (M. nemestrina) are susceptible to HIV-1 infection in vivo (Agy et al., 1992; Alter et al., 1984; Fultz et al., 1986; Gajdusek et al., 1985; Lusso et al., 1988; Nara et al., 1987) , whereas various primates [humans, rhesus monkeys (Macaca mulatta), cynomolgus monkeys (M. fascicularis), pig-tailed monkeys, and sooty mangabeys] are productively infected with viruses of the HIV-2 subgroup (Benveniste et al., 1988; Daniel et al., 1985; Dewhurst et al., 1990; Franchini et al., 1990; Letvin et al., 1985; Naidu et al., 1988) . In cultured peripheral blood mononuclear cells (PBMC), growth of HIV-1 is similarly restricted . However, a chimeric HIV-1/SIVMA c virus carrying tat, rev, vpu and env of HIV-1, and long terminal repeats (LTR), gag, pol, vif and vpx of SIVMA c can replicate in monkey PBMC . In this report, using several approaches, we studied the virological bases for the replication defect of HIV-1 in monkey cells. We demonstrate here that HIV-1 replication in monkey 
Methods
Celh'. PBMC from humans and cynomolgus monkeys were separated from heparinized whole blood of normal donors, stimulated with 10 ~tg/ml of concanavalin A for 24 h, and maintained in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum (FCS) and human interleukin-2 . Lymphoid cell lines derived from human (M8166; Shibata et al., 1991) , macaque monkey (Si2, Ohtsuki et al., 1984; SiIIA, Miyamoto et al., 1990 and PRI-PG1, unpublished) , and mouse (EL-4; ATCC TIB 39) were maintained in RPMI 1640 medium containing 10 % FCS. A human colon carcinoma cell line SW480 (Adachi et al., 1986) was maintained in Dulbecco's modified Eagle's medium containing 10 % FCS.
DNA constructs. All constructs were made from infectious molecular clones of HIV-1 (pNL432) (Adachi et al., 1986) and SIVMA c (pMA239) by standard recombinant DNA techniques (Fig.  1) . Nucleotide sequence data are from GenBank database (accession numbers M19921 for HIV-I NL432 and M33262 for SIVr~Ac 239). LTR-chloramphenicol acetyltrausferase (CAT) constructs of HIV-1 and SIVMA c (pill-CAT and pMA-CAT, respectively) and an HIV-1 tat expression plasmid (ptatl) have been described previously (Sakuragi et al., 1991) . Chimeric clones were constructed by inserting appropriate DNA fragments excised from one proviral clone into another. DNA fragments with incompatible end structures were ligated by blunt-end ligation or by linker insertion. When necessary, a chimeric subclone was initially constructed, then a chimeric fragment was excised and inserted into an appropriate proviral clone. Proviral clones carrying the CAT gene were constructed by inserting a 784 bp HindIII-Sau3AI fragment of pSV2-CAT (Gorman et al., 1982) into appropriate clones. Plasmid pNLenvCAT was constructed by inserting the CAT gene between the SspI and the other SspI sites of pNL432. Plasmid pMAuefCAT-Sc contains a 4 bp deletion at the SacI site of pMAnefCAT, which carries the CAT gene at the NcoI site of pMA239. Plasmid pMAnefCAT-C was made by inserting an XbaI termination codou linker (New England Biolabs) at the ClaI site of pMAnefCAT. An HIV-1 env expression plasmid pNLABS was constructed by deleting the sequence between the BssHII and SspI sites of pNL432. An SIV~A c env expression plasmid, prcNM-1ABS, carries the sequence from SphI to NcoI of pMA239 between the BssHII and XhoI sites of pNL432.
Transfection. SW480 and lymphoid cells were transfected with uncleaved plasmid DNAs by the calcium phosphate coprecipitation (Adachi et al., 1986 ) and the DEAE-dextran (Sodroski et al., 1986) methods, respectively.
Infection. Culture supernatants of virus-producing cells were filtered (0.45 ~tm pore size), and appropriate volumes were used for infection as described previously (Folks et al., 1985) . For infection with the retrovectors carrying the CAT gene ( Fig. 1 ) cells were extensively washed 5 h after inoculation to remove CAT activity in the supernatants.
RT assay. Viriomassociated reverse transcriptase (RT) activity was measured as described previously (Willey et al., 1988) .
Western immunoblotting. Cell lysates were prepared as previously described (Willey et al., 1988) then proteins were resolved on 12% SDS~polyacrylamide gels, followed by electrophoretic transfer to nitrocellulose membranes. The membranes were incubated at room temperature with an antiserum overnight and with 12SI-labelled Protein A for 3 h, washed, and then visualized by autoradiography (Willey et al., 1988) . Viral proteins were detected using human and monkey sera from infected individuals, a monoclonal antibody against HIV-I gag p24 (Cellular Products) a rabbit antiserum against HIV-1 nefpeptide (a gift from Y. Takebe) and a rabbit antiserum against HIV-1 vzfpeptide (unpublished).
CAT assay. CAT assays were performed as previously described (Gorman et al., 1982) .
PCR analysis. Low molecular weight DNA extracted from lymphoid cells 18 h after infection by the procedure of Hirt (1967) was used for amplification in the polymerase chain reaction (PCR). Oligonucleotide primers AATGAGGAAGCAGCAGAATGGGA (96 % identity with the pNL432 sequence from nt 1405 to 1427, and 83 % identity with the pMA239 sequence from nt 1674 to nt 1696) and TTACATTCTGG-GTTAGCATTTT (90 % identity with pNL432 sequence from nt 1781 to nt 1760, and 90 % identity with the pMA239 sequence from nt 2047 to nt 2026) were used to detect HIV-1 and SIV~A c gag sequences. This primer pair can be used to efficiently amplify the gag region of various HIV/SIV strains (unpublished observations). Oligonucleotide primers TGCTGTTAAATGGCAGTCTAGC (100 % identity with the pNL432 sequence from nt 6990 to nt 7011) and CCAGACTGTGA-GTTGCAACAG (identical to SK69; Ou et al., 1988 , 100% identity with the pNL432 sequence from nt 7927 to nt 7907, were used to detect the HIV-1 env sequence. PCR reaction mixtures contained 0.1 ~tg/ml of Hirt DNA, 1 taM of each primer, 0-2 mM-dNTPs, 10 mM-Tris-HC1 pH 8.9, 1.2 mM-MgC12, 80 mM-KC1, 500 lag/ml BSA, 0-1% sodium deoxycholate, 0.1% Triton X-100, and 0.1 U/ml of Tth DNA polymerase (Toyobo). The reaction mixture was subjected to 40 cycles of denaturation for 60 s at 90 °C, primer annealing for 90 s at 57 °C, and DNA synthesis by Tth DNA polymerase for 120 s at 72 °C. PCR products were electrophoresed through a 1% agarose gel, blotted onto nylon membranes, and hybridized with a2P-labelled DNA probes. To obtain semi-quantitative data, the intensity of the specific bands on autoradiograms was determined using a densitometer. Probe DNAs were prepared from the restriction fragments using a random primer DNA labelling kit (Takara Shuzo, Kyoto, Japan); a Pstl-PstI (nt 1415-2839) fragment of pNL432 for HIV-1 gag probe, a Pstl-PstI (nt 1684-3141) fragment of pMA239 for SIV~A c gag probe and a BglII-BgllI (nt 7031 7611) fragment of pNL432 for HIV-1 env probe.
Results

Generation and characterization of chimeric viruses between HIV-1 and SIVMA c
A new series of chimeric viruses between HIV-1 NL432 and SIV•A c 239 was constructed (Fig. 1 ) in order to identify the viral determinant(s) for the host range restriction of HIV-1. As reported previously (Shibata et al., 1991) the rcNM-3 virus carrying LTR, gag, pol, vif and vpx of SIVMA c and tat, rev, vpu and env of HIV-1 determine growth ability in PBMC of various viruses, cells were infected with ceil-flee virus samples and virus growth was monitored for 25 days. RT production in the culture fluids was determined, and the cultures that produced RT activity higher than 7 x 104 c.p.m./ml were scored as (+); viral replication was detected by PCR (Fig. 4) . replicated in monkey PBMC as efficiently as one of the parental viruses, SIV~A c. Three other chimeric clones (prcNM-3n, prcNM-8 and prcNM-9) were designed to contain less SIVMAc sequence than the prcNM-3 (Fig. 1) . They were constructed so as not to impair the five essential genes (gag, pol, env, tat and rev) or the vtfgene. Some of the other genes (vpx, vpr and neJ) were sacrificed because of the lack of appropriate conserved restriction sites. Upon transfection into SW480 cells, these three clones generated progeny virions infectious for the human CD4 + cell line M8166 (Fig. 1) . The structures of the chimeric viruses grown in M8166 cells were confirmed to be correct by Western immunoblotting using various antisera listed in Methods (data not shown).
Growth capabilities of chimeric viruses in human and monkey PBMC were examined to determine whether their tropism is HIV-l-type (replicates only in human PBMC) or SIV~Ac-type (replicates in both PBMC). Human and monkey PBMC were inoculated with supernatants of SW480 cells transfected with the viral clones and viral replication was monitored by measuring RT activity (Fig. 1) . The tropism of the rcNM-3 virus has been shown to be of the SIVMA c type (Fig. 1) . The rcNM-3n virus replicated in both PBMC (Fig. 1) , indicating that its tropism was also of the SIV~A c type and that the 5' half of LTR (including the 5' 70 % of the U3 region), tat, rev, vpu, env and nefof HIV-1 (Fig. 1) were not responsible for the replication defect of HIV-1 in monkey cells. The tropism of rcNM-9, which carried SIVMA c sequence instead of the HIV-1 central genomic region, was HIV-1 type (Fig. 1) . Although replication of the rcNM-8 virus in PBMC was not detected by RT assay, it could infect these cells (see below). The data presented in Fig. 1 showed that sequence encompassing the 3' half of LTR and gag-pol region was critical for monkey cell tropism. 
Absence of the late replication block of HIV-1 in monkey PBMC
The transcriptional activity of HIV-1 and SIVMA c LTRs was evaluated using the LTR-CAT system. Since the transfection efficiency of primary PBMC was low, and the cells were not technically suitable for this experiment, three macaque lymphoid cell lines established from primary PBMC were used instead (Miyamoto et al., 1990; Ohtsuki et al., 1984 ; X. Jiang et aI., unpublished results). The HIV-1 tat expression vector ptat 1 (Sakuragi et al., 1991) , an efficient transactivator for various HIV/SIV LTRs, was cotransfected with the LTR-CAT constructs to augment CAT production to a detectable level. As shown in Table 1 , CAT activity directed by the HIV-1 LTR (pHI-CAT) in human M8166 cells was 1.5-fold higher than that directed by the SIVMA c LTR (pMA-CAT). In monkey cell lines the ratios were similar or even greater. Therefore, it was unlikely that the HIV-1 promoter was specifically inefficient in the monkey cells.
The restriction of HIV-1 replication in monkey PBMC was further evaluated by transfection/coculture experiments (Table 2) would bypass the early phase of replication (adsorption, penetration, uncoating and reverse transcription), intracellular restriction affecting viral gene expression could be examined. The molecular clones of the HIV-1-type viruses (pNL432 and prcNM-9) and the SIVMA ctype viruses (pMA239 and prcNM-3) were transfected into human and monkey PBMC. On the following day, the PBMC were cocultured with M8166 cells, and monitored for virus production for 4 weeks. Mocktransfected human and monkey PBMC, and UV-killed human PBMC served as negative controls. All cultures except for the negative controls exhibited viral cytopathic effects (CPE) and produced RT activity within 3 weeks. HIV-l-type viruses appeared earlier than SIVMAc-type viruses in cocultured monkey PBMC and M8166 cells. These data showed that transcription, translation and virion assembly of HIV-1 were not blocked in monkey PBMC.
Analysis of the early HIV-1 replication step using the CA T assay system
The data obtained so far suggested that the replication of HIV-1 in monkey cells was blocked during the early stage of the virus life cycle. To examine the early phase defect of HIV-1 further, a new system to quantify viral infectivity (from virus entry to transcription) similar to . Four days later, samples were prepared for CAT assay. The conversion (%) of chloramphenicol to its acetylated forms is indicated. White and black bars represent the results obtained with human and monkey PBMC, respectively. As a negative control, pUC19 was used.
those previously described (Helseth et al., 1990; Page et al., 1990) was established (Fig. 1) . This system, which depends upon trans-complementation for production of infectious vector virus, makes use of a replicationdefective proviral clone containing the CAT gene (pNLenvCAT in Fig. 1 ). When appropriate viral clones ( Fig. 1) are cotransfected, infectious virus capable of undergoing the early steps of replication is generated. The CAT activity expressed in cells after infection with the virus provides a measure of the efficiency with which viral early replication phase proceeds. In addition to the constructs for trans-complementation, SIVMA c proviruses containing the CAT gene in the nef region ( Fig.   1 ) were constructed for use as controls. Fig. 2 shows the typical CAT activity observed in the target M8166 cells. Upon transfection into SW480 cells, pNLenvCAT expressed CAT and RT efficiently. However, because of the lack of Env gpl20, no significant CAT activity was , and low molecular weight DNAs were extracted from the PBMC 18 h later. Cr, mockinfection. The gag (NL432 and rcNM-3) and env (rcNM-8 and rcNM-9) regions were amplified by PCR and hybridized with ~2P-labelled DNA fragments as described in Methods. The intensity of the specific bands on autoradiograms was determined by a densitometer. Relative DNA amounts are shown. Black and white bars represent the results obtained with human and monkey PBMC, respectively. detected in M8166 cells infected with the virus produced from transfected SW480 cells (Fig. 2) . About a 100-fold increase in M8166 CAT activity was observed when the Env-expressing plasmid pNLABS was cotransfected into SW480 cells with the pNLenvCAT (Fig. 2) .
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The early stage of HIV-1 replication in monkey PBMC was examined using the system described above. The same virus samples (supernatants of transfected SW480 cells) were used to infect human and monkey PBMC isolated on the same day. As shown in Fig. 3 , human and monkey PBMC inoculated with the dual-tropic MAnefCAT-Sc virus produced a similar level of CAT activity significantly higher than that by the Env control virus MAnefCAT-C. In contrast, only human PBMC were infected with the supernatants from SW480 cells cotransfected with pNLenvCAT and pNLABS. These data indicated that the replication of HIV-1 in monkey PBMC was blocked ahnost completely in a single round of infection, and that the critical stage(s) occurred before transcription. Consistent with the data in Fig. 1 , the SIVuAc Env protein expressed by prcNM-1ABS did not confer the monkey cell tropism on the HIV-l-based retrovector pNLenvCAT.
Viral DNA synthesis in monkey PBMC
To determine whether DNA synthesis (reverse transcription) of HIV-1 occurs in monkey PBMC, viral DNAs in PBMC infected with the HIV-1-type or SIVMA ctype viruses were examined. Low molecular weight DNAs were extracted from human and monkey PBMC 18 h after infection, gag and env sequences were amplified by PCR, then probed with a2P-labelled viral DNA fragments. The presence of viral DNA in the inocula was checked by PCR of mouse EL-4 cells infected with virus and those free from viral DNA were used. Fig. 4 shows representative results. Human and monkey PBMC were infected with HIV-1 NL432 or rcNM-3 (SIVMa c tropism) (Fig. 1 ) and the gag sequence was amplified. A similar amount of amplified product was observed in rcNM-3-infected human and monkey PBMC. In contrast, a dramatic difference was noted between human and monkey PBMC infected with HIV-1 NL432. A similar result was obtained when env sequence was amplified (data not shown). To determine the HIV-1 factor responsible for the inefficient reverse transcription, human and monkey PBMC were inoculated with two other chimeric virus clones. An amplified env product was detected in both human and monkey PBMC infected with rcNM-8 (Fig. 4) , suggesting that the LTR, gag, and pol of SIVMA c were sufficient for the reverse transcription in monkey cells. In agreement with the HIV-1 tropism of rcNM-9 (Fig. 1 ) the amplified product of rcNM-9 was detected only in human PBMC (Fig. 4) .
Discussion
The major conclusions drawn from this study are that HIV-1 replication in monkey cells is blocked at a very early stage (uncoating and reverse transcription) and that the viral determinant responsible for this restriction resides in the sequence encompassing the 3' half of the LTR and the gag pol region. Little or no viral DNA was synthesized in monkey cells infected with viruses bearing that sequence derived from HIV-1 (Fig. 4) and spreading, productive infection did not occur (Fig. 1) . However, the difference in results obtained for the construct rcNM-8 as shown in Figs 1 and 4 raises a possibility that, at the level of virus production, additional factors may play a role beyond those assessed by cDNA synthesis.
The replication process of HIV-1 in monkey cells was analysed using several systems (Tables l and 2 (Table 1) . Infectious viruses were produced by monkey PBMC transfected with the HIV-l-type DNA clones ( Table 2) , showing that the synthesis of viral proteins and virion assembly were not blocked. In contrast, a significant blockade of HIV-1 replication was observed in the early stage of virus replication, that is, before or during reverse transcription. Virus DNA was barely detectable in monkey PBMC inoculated with HIV-1 (Fig. 4) . This early replication block was also noted in single step infection assays using retrovirus vectors carrying the CAT gene. Monkey PBMC could not be infected with the HIV-l-based vectors (Fig. 3) . Of note is that the Env proteins are not involved in this host range restriction. Chimeric viruses NM-3, NM-3n, and NM-8, which carry the HIV-1 env, grew in monkey PBMC (Fig. I) . The SIVMA c Env did not confer the monkey cell tropism on the HIV-1 vector (Fig.  3) . Therefore, the infection process mediated by the Env proteins (adsorption and penetration) is most unlikely to be a critical step for the restriction.
The viral proteins Tat, Rev, Vpu and Nef, which function at a stage later than proviral integration (Cullen & Greene, 1990) , did not contribute to the host range restriction studied here. In fact, the chimeric virus rcNM3n, carrying these genes derived from HIV-1, replicated quite well in monkey PBMC (Fig. 1) . It is also unlikely that non-essential gene products are the viral determinant for the monkey cell tropism, from the following observations: (i) Monkey PBMC were efficiently infected with the SIVMAc-based vector carrying a mutation in the v/f (MAnefCAT-Sc) (Fig. 3). (ii) The rcNM-9 virus, carrying the vzfand vpx of SIVMA c, exhibited HIV-l-type tropism (Fig. 1) . (iii) The reverse transcription in monkey PBMC infected with the rcNM-8 virus, which carries the v/f and vpr of HIV-1, appeared to be normal (Fig. 4) .
Based upon these results, we conclude that the factor(s) of HIV-1 responsible for the inefficient reverse transcription in monkey cells resides within the region encompassing the 3' half of LTR and gag-pol of the HIV-1 genome. This genomic region contains, other than gag and pol genes, some important cis-acting elements which may be associated with inefficient reverse transcription. These include the primer binding site (Rhim et al., 1991) , the secondary structure required for the efficient initiation of reverse transcription (Cobrinik et al., 1988) , and the central copy of the polypurine tract (Charneau & Clavel, 1991) . The early events of viral infection must be examined in detail if we are to understand fully the mechanism of the resistance of monkey cells to HIV-1 infection.
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